1. Home
  2. PGEN vs KALU Comparison

PGEN vs KALU Comparison

Compare PGEN & KALU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

N/A

Current Price

$7.02

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Logo Kaiser Aluminum Corporation

KALU

Kaiser Aluminum Corporation

N/A

Current Price

$115.15

Market Cap

3.0B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
PGEN
KALU
Founded
1998
1946
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.0B
IPO Year
2013
2006

Fundamental Metrics

Financial Performance
Metric
PGEN
KALU
Price
$7.02
$115.15
Analyst Decision
Buy
Buy
Analyst Count
4
5
Target Price
$13.65
★ $141.00
AVG Volume (30 Days)
★ 4.5M
327.1K
Earning Date
11-04-2026
10-21-2026
Dividend Yield
N/A
★ 2.57%
EPS Growth
N/A
★ 135.89
EPS
0.03
★ 11.26
Revenue
$230,981,000.00
★ $1,585,900,000.00
Revenue This Year
$2,335.22
$39.77
Revenue Next Year
$85.34
N/A
P/E Ratio
$223.17
★ $10.66
Revenue Growth
N/A
N/A
52 Week Low
$3.04
$88.00
52 Week High
$8.98
$199.89

Technical Indicators

Market Signals
Indicator
PGEN
KALU
Relative Strength Index (RSI) 50.05 32.67
Support Level $6.57 $105.45
Resistance Level $7.44 $154.48
Average True Range (ATR) 0.42 7.11
MACD -0.03 -2.60
Stochastic Oscillator 55.14 20.48

Price Performance

Historical Comparison
PGEN
KALU

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About KALU Kaiser Aluminum Corporation

Kaiser Aluminum Corp specializes in the production of semi-fabricated specialty aluminum mill products, such as aluminum plate and sheet, bare and coated coil and extruded and drawn products, for the end market applications: Aero/HS Products; Packaging; GE Products; and Automotive Extrusions. Its products include fabricated aluminum mill products such as flat-rolled (plate, sheet, and coil), extruded (rod, bar, hollows, and shapes), drawn (rod, bar, pipe, tube and wire) and certain cast aluminum products. Geographically, the company generates majority of its revenue from the United States.

Share on Social Networks: